ArticleBJU international2026

Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST).

Ankur Malpani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.